Skip to main content

Table 1 Characteristics of patients with gastric cancer in TCGA-STAD data

From: Construction of an RNA modification-related gene predictive model associated with prognosis and immunity in gastric cancer

 

Alive

Dead

Total

 

258

70

328

Age (years)

Mean

64.7

67.4

65.2

Median

66

68.5

67

 > 67

116 (45%)

42 (60%)

158 (48.2%)

 ≤ 67

142 (54%)

28 (40%)

170 (51.8%)

Gender

Female

101 (39.1%)

14 (20%)

115 (35.1%)

Male

157 (60.9%)

56 (80%)

213 (64.9%)

T stage

T1

14 (5.4%)

1 (1.4%)

15 (4.6%)

T2

54 (20.9%)

12 (17.2%)

66 (20.1%)

T3

116 (45%)

36 (51.4%)

152 (46.3%)

T4

74 (28.7%)

21 (30%)

95 (29%)

TX

0 (0%)

0 (0%)

0 (0%)

N stage

N0

85 (33%)

14 (20%)

99 (30.2%)

N1

67 (26%)

16 (22.9%)

83 (25.3%)

N2

53 (20.5%)

16 (22.9%)

69 (21%)

N3

47 (18.2%)

22 (31.3%)

69 (21%)

NX

6 (2.3%)

2 (2.9%)

8 (2.5%)

M stage

M0

235 (91.1%)

56(80%)

291 (88.7%)

M1

11 (4.3%)

11(15.7%)

22 (6.7%)

MX

12 (4.6%)

3(4.3%)

15 (4.6%)

Stage

I

34 (13.2%)

9 (12.9%)

43 (13.1%)

II

96 (37.2%)

8 (11.4%)

104 (31.7%)

III

108 (41.9%)

31 (44.3%)

139 (42.4%)

IV

15 (5.8%)

18 (25.7%)

33 (10.1%)

X

5 (1.9%)

4 (5.7%)

9 (2.7%)